Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side

Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are currently available for the management of type 2 diabetes mellitus. SGLT2i acts by inhibiting renal SGLT2, thereby increasing glucosuria and lowering serum glucose. Recent trials are emerging supporting a role for SGLT2i irrespective of the diab...

Full description

Bibliographic Details
Main Authors: Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel-Rahman
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
SGLT2i
non-diabetics
CKD
blood pressure
IgAN
FSGS
Online Access:https://www.mdpi.com/2077-0383/13/4/956

Internet

https://www.mdpi.com/2077-0383/13/4/956

Similar Items